ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Reva moves into peripheral artery disease with CE mark for bioresorbable scaffold
July 31, 2018Reva Medical received a CE mark for a new drug-eluting bioresorbable scaffold, which it described as the first device of its type to receive approval for the treatment of below-the-knee peripheral artery disease. The San Diego-based company expects to see
Pharma Sources Insight January 2025
